Bill Introduced to Expand Access to Lung Cancer Screening
The bill would enable healthcare organizations to purchase new mobile cancer screening units under a program within the HRSA, with an emphasis on lung cancer.
Read moreMain Content
CDC Alert: Use Only Sterile Ultrasound Gel for Percutaneous Procedures
May 20, 2025
The Centers for Disease Control and Prevention (CDC) alerted healthcare facilities about non-sterile ultrasound gel products — MediChoice® [lots: 240302 and 240306] and ClearImage® [lots: 230221, 230256, 240227, and 240230] — contaminated with an environmental bacterium, Paraburkholderia fungorum. The CDC confirmed 40 cases of P. fungorum in patients who were exposed to contaminated non-sterile ultrasound gel products in four states.
The agency urges healthcare providers to ensure patient safety by only using single-use ultrasound gels that are labeled “sterile” before and during percutaneous procedures. The full alert and more information is on the CDC website.
Related ACR News
ACR Urges HHS to Promote Annual Lung Cancer Screenings
In a recent comment letter, the College presented updated data that highlights the life-saving potential of lung cancer screening.
Read moreFDA Approves Alternative Standard Breast Density Reporting
The Alternative Standard will allow the physician to provide an overall assessment of breast density with singular phrasing in reports of unilateral mammograms.
Read more